Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John Weroha

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2004
Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI ratsJonathan J Li, S John Weroha, Wilma L Lingle, et al.
Plos One|May 12, 2015
Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraftGretchen Glaser, S John Weroha, Marc A Becker, et al.
Gynecologic Oncology Reports|December 17, 2025
Mucinous ovarian neoplasm - outcomes of a rare tumorBahareh Hamedi, Shilpa Mokshagundam, Antonio Lembo, et al.
BMC Cancer|October 22, 2016
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancerMarc A Becker, Xiaonan Hou, Piyawan Tienchaianada, et al.
Gynecologic Oncology Reports|May 6, 2022
High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomasKatherine C Kurnit, Meghan Steiner, Ricardo R Lastra, et al.
BMC Medical Genomics|June 23, 2021
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencingJaime I Davila, Pritha Chanana, Vivekananda Sarangi, et al.
Plos One|November 22, 2019
Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-ADiogo Torres, Xiaonan Hou, Laurie Bale, et al.
American Journal of Clinical Oncology|October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian CancerAminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.
Molecular Carcinogenesis|January 25, 2002
Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancerJonathan J Li, Dan Papa, Marilyn F Davis, et al.
Gynecologic Oncology Reports|December 4, 2025
<i>MECOM</i> amplified endometrial cancer, a novel subset of copy number high tumors associated with poor prognosisShariska P Harrington, Jacqueline Romani, Aminah Jatoi, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2004
Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI ratsJonathan J Li, S John Weroha, Wilma L Lingle, et al.
Plos One|May 12, 2015
Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraftGretchen Glaser, S John Weroha, Marc A Becker, et al.
Gynecologic Oncology Reports|December 17, 2025
Mucinous ovarian neoplasm - outcomes of a rare tumorBahareh Hamedi, Shilpa Mokshagundam, Antonio Lembo, et al.
BMC Cancer|October 22, 2016
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancerMarc A Becker, Xiaonan Hou, Piyawan Tienchaianada, et al.
Gynecologic Oncology Reports|May 6, 2022
High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomasKatherine C Kurnit, Meghan Steiner, Ricardo R Lastra, et al.
BMC Medical Genomics|June 23, 2021
Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencingJaime I Davila, Pritha Chanana, Vivekananda Sarangi, et al.
Plos One|November 22, 2019
Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-ADiogo Torres, Xiaonan Hou, Laurie Bale, et al.
American Journal of Clinical Oncology|October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian CancerAminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.
Molecular Carcinogenesis|January 25, 2002
Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancerJonathan J Li, Dan Papa, Marilyn F Davis, et al.
Gynecologic Oncology Reports|December 4, 2025
<i>MECOM</i> amplified endometrial cancer, a novel subset of copy number high tumors associated with poor prognosisShariska P Harrington, Jacqueline Romani, Aminah Jatoi, et al.
Pageof 9